Short answer
Apogee Therapeutics, Inc. (APGE) filed an 8-K current report with the SEC on March 2, 2026 reporting Item 2.02 (Results of Operations and Financial Condition). Full-year 2025 financial results released March 2, 2026: see Exhibit 99.1 for key figures.
Apogee Therapeutics, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Full-year 2025 financial results released March 2, 2026: see Exhibit 99.1 for key figures
- Filing also includes a business update, suggesting pipeline or operational developments beyond financials
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Apogee Therapeutics, Inc. 8-K filings
Get the next APGE 8-K as it lands
Follow APGE for push alerts, or ask the research agent what this filing means.